Literature DB >> 24515629

Interactions between dietary docosahexaenoic acid and other long-chain polyunsaturated fatty acids on performance and fatty acid retention in post-smolt Atlantic salmon (Salmo salar).

Brett D Glencross1, Douglas R Tocher, Chessor Matthew, J Gordon Bell.   

Abstract

A study with varying dietary inclusion levels (1, 5, 10, 15 and 20 g kg(-1)) of docosahexaenoic acid (DHA; 22:6n-3) was conducted with post-smolt (111 ± 2.6 g; mean ± S.) Atlantic salmon (Salmo salar) over a 9-week period. In addition to the series of DHA inclusion levels, the study included further diets that had DHA at 10 g kg(-1) in combination with either eicosapentaenoic acid (EPA; 20:5n-3) or arachidonic acid (ARA; 20:4n-6), both also included at 10 g kg(-1). An additional treatment with both EPA and DHA included at 5 g kg(-1) (total of 10 g kg(-1) long-chain polyunsaturated fatty acids, LC-PUFA) was also included. After a 9-week feeding period, fish were weighed, and carcass, blood and tissue samples collected. A minor improvement in growth was seen with increasing inclusion of DHA. However, the addition of EPA further improved growth response while addition of ARA had no effect on growth. As with most lipid studies, the fatty acid composition of the whole body lipids generally reflected that of the diets. However, there were notable exceptions to this, and these implicate some interactions among the different LC-PUFA in terms of the fatty acid biochemistry in this species. At very low inclusion levels, DHA retention was substantially higher (~250%) than that at all other inclusion levels (31-58%). The inclusion of EPA in the diet also had a positive effect on the retention efficiency of DHA. However, EPA retention was highly variable and at low DHA inclusion levels there was a net loss of EPA as this fatty acid was most likely elongated to produce DHA, consistent with increased DHA retention with additional EPA in the diet. Retention of DPA (22:5n-3) was high at low levels of DHA, but diminished with increasing DHA inclusion, similar to that seen with DHA retention. The addition of EPA to the diet resulted in a substantial increase in the efficiency of DPA retention; the inclusion of ARA had the opposite effect. Retention of ARA was unaffected by DHA inclusion, but the addition of either EPA or ARA to the diet resulted in a substantial reduction in the efficiency of ARA retention. No effects of dietary treatment were noted on the retention of either linolenic (18:3n-3) or linoleic (18:2n-6) acids. When the total n-3 LC-PUFA content of the diet was the same but consisted of either DHA alone or as a combination of EPA plus DHA, the performance effects were similar.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24515629     DOI: 10.1007/s10695-014-9917-8

Source DB:  PubMed          Journal:  Fish Physiol Biochem        ISSN: 0920-1742            Impact factor:   2.794


  11 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

2.  Interactions of saturated, n-6 and n-3 polyunsaturated fatty acids to modulate arachidonic acid metabolism.

Authors:  M L Garg; A B Thomson; M T Clandinin
Journal:  J Lipid Res       Date:  1990-02       Impact factor: 5.922

Review 3.  The role of polyunsaturated fatty acids in fish.

Authors:  M V Bell; R J Henderson; J R Sargent
Journal:  Comp Biochem Physiol B       Date:  1986

4.  Eicosapentaenoic acid as a modulator of inflammation. Effect on prostaglandin and leukotriene synthesis.

Authors:  T Terano; J A Salmon; G A Higgs; S Moncada
Journal:  Biochem Pharmacol       Date:  1986-03-01       Impact factor: 5.858

5.  Arachidonic acid metabolism in gill homogenate and isolated gill cells from rainbow trout, Oncorhynchus mykiss: the effect of osmolality, electrolytes and prolactin.

Authors:  B Beckman; T Mustafa
Journal:  Fish Physiol Biochem       Date:  1992-10       Impact factor: 2.794

6.  Essential fatty acids in the diet of rainbow trout (Salmo gairdneri): growth, feed conversion and some gross deficiency symptoms.

Authors:  J D Castell; R O Sinnhuber; J H Wales; D J Lee
Journal:  J Nutr       Date:  1972-01       Impact factor: 4.798

7.  Essential fatty acids in the diet of rainbow trout (Salmo gairdneri): physiological symptoms of EFA deficiency.

Authors:  J D Castell; R O Sinnhuber; D J Lee; J H Wales
Journal:  J Nutr       Date:  1972-01       Impact factor: 4.798

8.  Fatty acid metabolism (desaturation, elongation and beta-oxidation) in rainbow trout fed fish oil- or linseed oil-based diets.

Authors:  Giovanni M Turchini; David S Francis
Journal:  Br J Nutr       Date:  2009-01-05       Impact factor: 3.718

9.  Replacement of fish oil with thraustochytrid Schizochytrium sp. L oil in Atlantic salmon parr (Salmo salar L) diets.

Authors:  Matthew R Miller; Peter D Nichols; Chris G Carter
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2007-05-29       Impact factor: 2.320

10.  Fatty acid compositions of the major phosphoglycerides from fish neural tissues; (n-3) and (n-6) polyunsaturated fatty acids in rainbow trout (Salmo gairdneri) and cod (Gadus morhua) brains and retinas.

Authors:  D R Tocher; D G Harvie
Journal:  Fish Physiol Biochem       Date:  1988-10       Impact factor: 2.794

View more
  9 in total

1.  Uncoupling EPA and DHA in Fish Nutrition: Dietary Demand is Limited in Atlantic Salmon and Effectively Met by DHA Alone.

Authors:  James A Emery; Fernando Norambuena; Jesse Trushenski; Giovanni M Turchini
Journal:  Lipids       Date:  2016-03-11       Impact factor: 1.880

2.  Fatty acid-specific alterations in leptin, PPARα, and CPT-1 gene expression in the rainbow trout.

Authors:  Elena Coccia; Ettore Varricchio; Pasquale Vito; Giovanni Mario Turchini; David Scott Francis; Marina Paolucci
Journal:  Lipids       Date:  2014-08-10       Impact factor: 1.880

3.  Liver Transcriptome Profiling Reveals That Dietary DHA and EPA Levels Influence Suites of Genes Involved in Metabolism, Redox Homeostasis, and Immune Function in Atlantic Salmon (Salmo salar).

Authors:  Xi Xue; Jennifer R Hall; Albert Caballero-Solares; Khalil Eslamloo; Richard G Taylor; Christopher C Parrish; Matthew L Rise
Journal:  Mar Biotechnol (NY)       Date:  2020-02-10       Impact factor: 3.619

4.  The Inclusion of the Microalga Scenedesmus sp. in Diets for Rainbow Trout, Onchorhynchus mykiss, Juveniles.

Authors:  Ali Skalli; Joana P Firmino; Karl B Andree; Ricardo Salomón; Alicia Estévez; Patricia Puig; Mar Sabater-Martínez; Teresa Hechavarria; Enric Gisbert
Journal:  Animals (Basel)       Date:  2020-09-15       Impact factor: 2.752

5.  A comparative analysis of the response of the hepatic transcriptome to dietary docosahexaenoic acid in Atlantic salmon (Salmo salar) post-smolts.

Authors:  Brett D Glencross; Christian De Santis; Beatrix Bicskei; John B Taggart; James E Bron; Monica B Betancor; Douglas R Tocher
Journal:  BMC Genomics       Date:  2015-09-07       Impact factor: 3.969

6.  Atlantic salmon require long-chain n-3 fatty acids for optimal growth throughout the seawater period.

Authors:  Grethe Rosenlund; Bente E Torstensen; Ingunn Stubhaug; Nafiha Usman; Nini H Sissener
Journal:  J Nutr Sci       Date:  2016-05-11

7.  Isolation and Functional Characterisation of a fads2 in Rainbow Trout (Oncorhynchus mykiss) with Δ5 Desaturase Activity.

Authors:  Noor Khalidah Abdul Hamid; Greta Carmona-Antoñanzas; Óscar Monroig; Douglas R Tocher; Giovanni M Turchini; John A Donald
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

8.  Genetic effects of fatty acid composition in muscle of Atlantic salmon.

Authors:  Siri S Horn; Bente Ruyter; Theo H E Meuwissen; Borghild Hillestad; Anna K Sonesson
Journal:  Genet Sel Evol       Date:  2018-05-02       Impact factor: 4.297

Review 9.  Microbial and genetically engineered oils as replacements for fish oil in aquaculture feeds.

Authors:  M Sprague; M B Betancor; D R Tocher
Journal:  Biotechnol Lett       Date:  2017-07-18       Impact factor: 2.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.